EU/1/02/238/001 |
41411 |
Zavesca 100 mg kapsuly |
cps dur 84x100 mg (blis.Aclar/Al) |
JNS |
|
EU/1/02/246/001 |
41550 |
Carbaglu 200 mg dispergovate?né tablety |
tbl dsp 15x200 mg (obal PP) |
OEU-1 |
|
EU/1/02/246/002 |
41551 |
Carbaglu 200 mg dispergovate?né tablety |
tbl dsp 60x200 mg (obal PP) |
OEU-1 |
|
EU/1/02/246/003 |
97768 |
Carbaglu 200 mg dispergovate?né tablety |
tbl dsp 5x200 mg (obal PP) |
OEU-1 |
|
EU/1/06/342/001 |
36227 |
Nexavar 200 mg filmom obalené tablety |
tbl flm 112x200 mg (blis.PP/Al) |
BAY |
|
EU/1/06/378/001 |
37866 |
Inovelon 100 mg filmom obalené tablety |
tbl flm 10x100 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/002 |
37867 |
Inovelon 100 mg filmom obalené tablety |
tbl flm 30x100 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/003 |
37868 |
Inovelon 100 mg filmom obalené tablety |
tbl flm 50x100 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/004 |
37869 |
Inovelon 100 mg filmom obalené tablety |
tbl flm 60x100 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/005 |
37870 |
Inovelon 100 mg filmom obalené tablety |
tbl flm 100x100 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/006 |
37871 |
Inovelon 200 mg filmom obalené tablety |
tbl flm 10x200 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/007 |
37872 |
Inovelon 200 mg filmom obalené tablety |
tbl flm 30x200 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/008 |
37873 |
Inovelon 200 mg filmom obalené tablety |
tbl flm 50x200 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/009 |
37874 |
Inovelon 200 mg filmom obalené tablety |
tbl flm 60x200 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/010 |
37875 |
Inovelon 200 mg filmom obalené tablety |
tbl flm 100x200 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/011 |
37876 |
Inovelon 400 mg filmom obalené tablety |
tbl flm 10x400 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/012 |
37877 |
Inovelon 400 mg filmom obalené tablety |
tbl flm 30x400 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/013 |
37878 |
Inovelon 400 mg filmom obalené tablety |
tbl flm 50x400 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/014 |
37879 |
Inovelon 400 mg filmom obalené tablety |
tbl flm 60x400 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/015 |
37880 |
Inovelon 400 mg filmom obalené tablety |
tbl flm 100x400 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/016 |
37881 |
Inovelon 400 mg filmom obalené tablety |
tbl flm 200x400 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/017 |
31927 |
Inovelon 40 mg/ml perorálna suspenzia |
sus por 1x460 ml/18,4 g (f?.PET) |
XEI-DE |
|
EU/1/07/391/001 |
43533 |
Revlimid 5 mg tvrdé kapsuly |
cps dur 21x5 mg (blis. PCTFE/PVC/Al) |
CLG-NL |
|
EU/1/07/391/002 |
43534 |
Revlimid 10 mg tvrdé kapsuly |
cps dur 21x10 mg (blis. PCTFE/PVC/Al) |
CLG-NL |
|
EU/1/07/391/003 |
43535 |
Revlimid 15 mg tvrdé kapsuly |
cps dur 21x15 mg (blis. PCTFE/PVC/Al) |
CLG-NL |
|
EU/1/07/391/004 |
43536 |
Revlimid 25 mg tvrdé kapsuly |
cps dur 21x25 mg (blis. PCTFE/PVC/Al) |
CLG-NL |
|
EU/1/07/391/005 |
3077A |
Revlimid 2,5 mg tvrdé kapsuly |
cps dur 21x2,5 mg (blis. PCTFE/PVC/Al) |
CLG-NL |
|
EU/1/07/391/006 |
3078A |
Revlimid 7,5 mg tvrdé kapsuly |
cps dur 21x7,5 mg (blis. PCTFE/PVC/Al) |
CLG-NL |
|
EU/1/07/391/007 |
6808A |
Revlimid 2,5 mg tvrdé kapsuly |
cps dur 7x2,5 mg (blis. PCTFE/PVC/Al) |
CLG-NL |
|
EU/1/07/391/008 |
6809A |
Revlimid 5 mg tvrdé kapsuly |
cps dur 7x5 mg (blis. PCTFE/PVC/Al) |
CLG-NL |
|
EU/1/07/391/009 |
6549B |
Revlimid 20 mg tvrdé kapsuly |
cps dur 21x20 mg (blis. PCTFE/PVC/Al) |
CLG-NL |
|
EU/1/07/391/010 |
5366C |
Revlimid 10 mg tvrdé kapsuly |
cps dur 7x10 mg (blis. PCTFE/PVC/Al) |
CLG-NL |
|
EU/1/07/391/011 |
5367C |
Revlimid 15 mg tvrdé kapsuly |
cps dur 7x15 mg (blis. PCTFE/PVC/Al) |
CLG-NL |
|
EU/1/07/393/001 |
43567 |
Soliris 300 mg infúzny koncentrát |
con inf 1x30 ml/300 mg (liek.inj.skl.) |
ALX-1 |
|
EU/1/07/417/001 |
45774 |
Yondelis 0,25 mg prášok pre koncentrát pre infúzny roztok |
plc ifc 1x0,25 mg (liek.inj.skl.) |
PMR |
|
EU/1/07/417/002 |
45775 |
Yondelis 1 mg prášok pre koncentrát pre infúzny roztok |
plc ifc 1x1 mg (liek.inj.skl.) |
PMR |
|
EU/1/07/422/001 |
46941 |
Tasigna 200 mg tvrdé kapsuly |
cps dur 28x200 mg (blis.PVC/PVDC/Al) púzdro |
NEH-IE |
|
EU/1/07/422/002 |
46942 |
Tasigna 200 mg tvrdé kapsuly |
cps dur 28x200 mg (blis.PA/Al/PVC/Al) púzdro |
NEH-IE |
|
EU/1/07/422/003 |
46943 |
Tasigna 200 mg tvrdé kapsuly |
cps dur 112(4x28)x200 mg (blis.PVC/PVDC/Al) púzdro |
NEH-IE |
|
EU/1/07/422/004 |
46944 |
Tasigna 200 mg tvrdé kapsuly |
cps dur 112(4x28)x200 mg (blis.PA/Al/PVC/Al) púzdro |
NEH-IE |
|
EU/1/07/422/005 |
03849 |
Tasigna 150 mg tvrdé kapsuly |
cps dur 28x150 mg (blis.PVC/PVDC/Al) |
NEH-IE |
|
EU/1/07/422/006 |
03850 |
Tasigna 150 mg tvrdé kapsuly |
cps dur 112(4x28)x150 mg (blis.PVC/PVDC/Al) |
NEH-IE |
|
EU/1/07/422/007 |
09719 |
Tasigna 200 mg tvrdé kapsuly |
cps dur 28x200 mg (blis.PVC/PVDC/Al) |
NEH-IE |
|
EU/1/07/422/008 |
09720 |
Tasigna 200 mg tvrdé kapsuly |
cps dur 112(4x28)x200 mg (blis.PVC/PVDC/Al) |
NEH-IE |
|
EU/1/07/422/009 |
11644 |
Tasigna 150 mg tvrdé kapsuly |
cps dur 40x150 mg (blis.PVC/PVDC/Al) |
NEH-IE |
|
EU/1/07/422/010 |
11645 |
Tasigna 150 mg tvrdé kapsuly |
cps dur 120(3x40)x150 mg (blis.PVC/PVDC/Al) |
NEH-IE |
|
EU/1/07/422/011 |
11646 |
Tasigna 200 mg tvrdé kapsuly |
cps dur 40x200 mg (blis.PVC/PVDC/Al) |
NEH-IE |
|
EU/1/07/422/012 |
11647 |
Tasigna 200 mg tvrdé kapsuly |
cps dur 120(3x40)x200 mg (blis.PVC/PVDC/Al) |
NEH-IE |
|
EU/1/07/422/013 |
0295C |
Tasigna 150 mg tvrdé kapsuly |
cps dur 392(14x28)x150 mg (blis.PVC/PVDC/Al) |
NEH-IE |
|
EU/1/07/422/014 |
0296C |
Tasigna 200 mg tvrdé kapsuly |
cps dur 392(14x28)x200 mg (blis.PVC/PVDC/Al) |
NEH-IE |
|